Insulet Corporation (PODD) is a publicly traded Healthcare sector company. As of July 7, 2026, PODD trades at $160.84 with a market cap of $11.39B and a P/E ratio of 37.22. PODD moved +0.68% today. Year to date, PODD is -44.34%; over the trailing twelve months it is -46.93%. Its 52-week range spans $138.79 to $354.88. Analyst consensus is strong buy with an average price target of $227.48. Rallies surfaces PODD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Insulet Corporation (PODD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PODD moved +0.68% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $160.84 |
| Market Cap | $11.39B |
| P/E Ratio | 37.22 |
| EPS | $4.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $354.88 |
| 52-Week Low | $138.79 |
| Volume | 219.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.90B |
| Net Income | $302.80M |
| Gross Margin | 71.01% |
22 analysts cover PODD: 0 strong buy, 18 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $227.48.